NDC11 16571026130
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16571-0261-30 | 16571-0261 |
| 16571-261-30 | 16571-261 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfasalazine | SULFASALAZINE | Rising Pharma Holdings, Inc. | 3254432e-87a4-4af0-afd1-d9e6f1b0efd4 | 2025-11-06 | Warnings, Adverse reactions | 16571-261-30 16571-261 16571026130 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.